Weekly outline
- General
- 1. 17 February - 23 February
1. 17 February - 23 February
A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmosalar L.).
- 2. 24 February - 2 March
2. 24 February - 2 March
Stability and efficacy of the 3'-UTR A4G-G5A variant of viral hemorrhagic
septicemia virus (VHSV) as a live attenuated immersion VHSV vaccine in
olive flounder (Paralichthys olivaceus). - 3. 3 March - 9 March
3. 3 March - 9 March
Use of Poly(I:C) Stabilized with Chitosan As a Vaccine-Adjuvant Against
Viral Hemorrhagic Septicemia Virus Infection in Zebrafish. - 4. 10 March - 16 March
4. 10 March - 16 March
A Review of Intra- and Extracellular Antigen Delivery Systems for Virus
Vaccines of Finfish.
IPNV Antigen Uptake and Distribution in Atlantic Salmon Following Oral
Administration. - 5. 17 March - 23 March
5. 17 March - 23 March
Sequence analysis and identification of new isoform of EP4 receptors in
different atlantic salmon tissues (Salmo salar L.) and its role in PGE2
induced immunomodulation in vitro. - 6. 24 March - 30 March
6. 24 March - 30 March
Difference in skin immune responses to infection with salmon louse
(Lepeophtheirus salmonis) in Atlantic salmon (Salmo salar L.) of families
selected for resistance and susceptibility. - 7. 31 March - 6 April
7. 31 March - 6 April
Interferon regulatory factor-1 (IRF-1) is involved in the induction of
phosphatidylserine receptor (PSR) in response to dsRNA virus infection
and contributes to apoptotic cell clearance in CHSE-214 cell. - 8. 7 April - 13 April
8. 7 April - 13 April
Augmentation of the antibody response of Atlantic salmon by oral administration of alginate-encapsulated IPNV antigens.
- 9. 14 April - 20 April
- 10. 21 April - 27 April
10. 21 April - 27 April
Acquired immunity and vaccination against infectious pancreatic necrosis
virus of salmon. - 11. 28 April - 4 May
11. 28 April - 4 May
Acquired immunity and vaccination against infectious pancreatic necrosis
virus of salmon. - 12. 5 May - 11 May
12. 5 May - 11 May
The kinetics of CD4+ and CD8+ T-cell gene expression correlate with
protection in Atlantic salmon (Salmo salar L) vaccinated against infectious
pancreatic necrosis. - 13. 12 May - 18 May
13. 12 May - 18 May
Antigen dose and humoral immune response correspond with protection
for inactivated infectious pancreatic necrosis virus vaccines in Atlantic
salmon (Salmo salar L). - 14. 19 May - 25 May
14. 19 May - 25 May
Immunogenicity and cross protective ability of the central VP2 amino acids
of infectious pancreatic necrosis virus in Atlantic salmon (Salmo salar L.). - 15. 26 May - 1 June
15. 26 May - 1 June
Functional feeds reduce heart inflammation and pathology in Atlantic
Salmon (Salmo salar L.) following experimental challenge with Atlantic
salmon reovirus (ASRV). - 16. 2 June - 8 June
16. 2 June - 8 June
Antibody responses correlate with antigen dose and in vivo protection for
oil-adjuvanted, experimental furunculosis (Aeromonas salmonicida subsp.
salmonicida) vaccines in Atlantic salmon (Salmo salar L.) and can be used for batch potency testing of vaccines. - 17. 9 June - 15 June
17. 9 June - 15 June
Gene expression studies of host response to Salmonid alphavirus subtype
3 experimental infections in Atlantic salmon. - 18. 16 June - 22 June
《尊重智慧財產權，請使用正版教科書，勿非法影印書籍及教材，以免侵犯他人著作權》